Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. - Wikidata - wikimedia - TriplyDB

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

http://www.wikidata.org/entity/Q33738269

about

Lyme Disease The Past, Present, and (Possible) Future of Serologic Testing for Lyme Disease The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.Application of Bayesian decision-making to laboratory testing for Lyme disease and comparison with testing for HIV Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.Laboratory diagnosis of Lyme disease: advances and challenges Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013 Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada.Lyme disease testing by large commercial laboratories in the United States.Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.Development of a metabolic biosignature for detection of early Lyme disease.Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis Lyme disease caused by Borrelia burgdorferi with two homeologous 16S rRNA genes: a case report.Microfluidic biosensing systems using magnetic nanoparticles.Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease.Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of lyme disease with noncutaneous manifestations.Achieving molecular diagnostics for Lyme disease.Review: unraveling Lyme disease Nervous system Lyme disease, chronic Lyme disease, and none of the above.Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy.Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology.Blood donor Borrelia burgdorferi sensu lato seroprevalence and history of tick bites at a northern limit of the vector distribution.Early Disseminated Lyme Disease Causing False Positive Serology for Primary Epstein-Barr Virus Infection - Report of 2 Cases.Significant variations in the seroprevalence of C6 ELISA antibodies in a highly endemic area for Lyme borreliosis: evaluation of age, sex and seasonal differences.Neuroborreliosis.C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.Lyme disease in the United Kingdom.Nervous system lyme disease: diagnosis and treatment.Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department.Seroreactivity to the C6 Peptide in Borrelia Miyamotoi Infections Occurring in the Northeastern United States.

P2860

Q22250895-8EB2A396-769E-4090-AAC0-520E4270E5EE Q28075680-66A0A8BB-3E0A-47BC-9661-2FF41234813D Q28354112-A5938FEC-388E-4691-9488-0C658FEB09C3 Q30240203-81B29599-6FFD-404C-8DAA-F29CA4A4EACF Q30357899-C2E19CC2-39EF-44DA-9E4E-A01A2E622CA5 Q33565276-8CFCD447-240A-4609-B812-39191036E9C6 Q33601926-93DD1A55-0CEE-47E8-A928-C866662645A3 Q34568050-5953124E-D91C-44E9-80AD-B456AD5EE4D6 Q34701380-0232F286-2417-46B7-8F94-854EE46B0942 Q35638551-9E2696F4-00D7-4CAC-AB5E-D6D2DFDF12A3 Q36121502-C5DE2B9B-868F-4811-9610-5DC4EA653817 Q36275562-249B76A7-859B-4653-A4E6-6CC86537BD4A Q36283952-C6FA99EA-86F6-45EE-B4B8-F823090FCA0E Q36297670-B317C919-E11D-49E5-B1B5-9C3E91B588CF Q36489385-C60A6CA2-BDFE-4FD2-9173-2281244B33E8 Q36737157-CF94AB0E-1C86-4E98-8BAD-17B7B20E96A3 Q36764399-E4654F67-FB8A-4BE7-994D-B72C3832B204 Q36784433-964BE70B-9A51-496A-BABE-F693F33C728B Q36843172-D8969016-6075-4C69-8770-DA66BF98136E Q37225181-4F695108-B391-4715-90FE-3631A04A21DA Q37325470-87EA5203-11DD-4ABB-95AA-5E5B39C7AD2F Q37336154-F94E7C8E-745F-4DEC-824D-B0EAAB80BC0A Q38154932-0C5B8DBC-9D07-49ED-B2F5-74B3BC74CF49 Q38223310-12E86423-6EA3-48A6-BF9D-BBD8671CFBF1 Q38588148-2523F0D5-1CF9-4B6E-BF86-1F1655BEEBDE Q39128189-AE501D33-23A0-4C67-8C55-5A49FA30F501 Q40096920-8CD234D6-736B-45BA-89C4-B173CC447DD9 Q40160907-8F0B2F6A-4543-4A0B-B514-EB8F7EB09695 Q40257045-424D4F57-A001-48EA-9DFD-9C1249C83920 Q40324175-6CED1BF8-1AED-422C-AC3E-D4405D222583 Q40436486-722A986A-5BF4-4E43-BA0B-C00AFE0A7781 Q41121104-C65AE5DC-E01F-40B6-9224-267E49215789 Q41637638-93F6BAA8-7E78-41EA-9991-E10D3C2D26F5 Q42241649-DCE9846F-3704-4956-9785-4A6B6BE2581B Q44367190-37CE4D1A-A456-4F4C-A81A-24907EE2DE38 Q45223445-3D06D5AD-FC6D-45CB-A3DC-670F05A5546F Q46836151-143074CF-8D13-4CB7-A302-E6996A542D96 Q47920219-AA6939A0-485A-45B1-A2C1-EBCF13F49E74 Q49628856-FB76B350-1A99-4955-BD4A-F2450CC24123 Q49922011-D5FE7E58-D00A-4BC8-B0F7-6AB392245CC3

P2860

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

http://www.wikidata.org/entity/Q33738269

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Single-tier testing with the C ...... tier testing for Lyme disease.

@ast

Single-tier testing with the C ...... tier testing for Lyme disease.

@en

type

label

Single-tier testing with the C ...... tier testing for Lyme disease.

@ast

Single-tier testing with the C ...... tier testing for Lyme disease.

@en

prefLabel

Single-tier testing with the C ...... tier testing for Lyme disease.

@ast

Single-tier testing with the C ...... tier testing for Lyme disease.

@en

P1433

Q33738269-86286A23-7E38-428C-9241-2547EDE6E0C7

P1476

Q33738269-B0C8EDD3-DEC1-4E77-8DE2-F0B6E0F08282

P2093

Q33738269-22A2D910-16C7-45C4-9CCB-5A7BF4D6CDBC

Q33738269-2C333554-FD0D-46C6-B598-1BDD2D806697

Q33738269-3398B249-8672-4573-9949-1F16D677A0C2

Q33738269-60F59234-FAF1-49B0-8B02-E1B2D37668CC

Q33738269-6E643C7D-3698-4A40-9B0A-BF6A48E1C817

Q33738269-9A569A34-B50F-40F2-ADD8-DFBFF8333547

Q33738269-9EC38CB8-8C6C-4BCE-82B9-6C2E629C5C5B

Q33738269-AA78C025-28E7-487B-A4AD-3876AD90EEC1

P2860

Q33738269-010ECAF3-5756-4256-A9AE-0D89FA24DDEA

Q33738269-077D2F59-A3C4-4699-BF92-99B9F1FF6A35

Q33738269-0AA96DB3-73E3-4401-B0BD-30085FFCABD6

Q33738269-113774C7-B467-495E-9172-B601A4B6B039

Q33738269-23F38854-5910-4A0F-AB25-01688C187D6B

Q33738269-2BD29A67-9D20-406A-ABA5-643E914CFA30

Q33738269-411E0E10-5516-40E0-94F5-A3D8B016256F

Q33738269-4517866A-3EE3-4957-A94C-1FD3C43ED030

Q33738269-4B5337A3-1E9B-45E6-A0DD-BC67858667FF

Q33738269-4CD9267D-D5C3-4ECD-BD88-0260265C11A8

P304

Q33738269-EACE065B-CD99-41F5-A664-6A1B4587FBD1

P31

Q33738269-36A9FD2F-84C4-4E24-BEB2-D5DB54D85A85

P356

Q33738269-DF209C94-BC66-474B-9BBD-99631ED0CB8E

P433

Q33738269-EC7B4705-936D-4BD0-94C1-DB4827950E42

P478

Q33738269-AA125894-38FE-466D-8B6C-5B32FE7AF48C

P50

Q33738269-38E6DFB0-72ED-4891-8FA7-23D6A7764CF3

Q33738269-86934734-F052-4A77-AF56-FE3545518C5E

P577

Q33738269-EAE6B6E5-502A-4281-AB5F-6664EDBCD932

P5875

Q33738269-E7295C76-0E24-4392-87E0-85286BC4FA1A

P698

Q33738269-5B0502E0-8390-48F2-BA19-12D3C040C5D5

P921

Q33738269-7DCD6529-BD0F-4D0A-9658-E1FAFB0C7FE5

P932

Q33738269-CF92ACA9-A413-4116-837C-8C6E234EF6A3

P356

J.DIAGMICROBIO.2012.09.003

P1433

Diagnostic Microbiology and Infectious Disease

P1476

Single-tier testing with the C ...... tier testing for Lyme disease.

@en

P2093

Allen C Steere

http://www.w3.org/2001/XMLSchema#string

Barbara J B Johnson

http://www.w3.org/2001/XMLSchema#string

Gary P Wormser

http://www.w3.org/2001/XMLSchema#string

J Stephen Dumler

http://www.w3.org/2001/XMLSchema#string

John Nowakowski

http://www.w3.org/2001/XMLSchema#string

Maria E Aguero-Rosenfeld

http://www.w3.org/2001/XMLSchema#string

Martin Schriefer

http://www.w3.org/2001/XMLSchema#string

Robert B Nadelman

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis of lyme borreliosis.

Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

Prospective study of serologic tests for lyme disease.

Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis

Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.

Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.

Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens

Recombinant flagellin A proteins from Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii in serodiagnosis of Lyme borreliosis.

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

P304

9-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DIAGMICROBIO.2012.09.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Adriana Marques

P577

2012-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232245526

http://www.w3.org/2001/XMLSchema#string

P698

23062467

http://www.w3.org/2001/XMLSchema#string

P921

P932

4052829

http://www.w3.org/2001/XMLSchema#string